<DOC>
	<DOCNO>NCT01063491</DOCNO>
	<brief_summary>Aortocoronary bypass graft failure common associate high morbidity mortality . Failure saphenous vein graft common failure internal mammary artery graft . Whether early graft angiography reduce bypass graft failure remain unknown . The Cardiac CAtheterization Bypass Graft Patency Rate Optimization ( CABG-PRO ) randomized-controlled pilot study phase III , double-blind , randomized-controlled pilot trial randomize 170 patient undergoing coronary artery bypass graft surgery early ( dismissal ) graft angiography vs. early graft angiography . Coronary angiography perform 12 month , determine whether compare early graft angiography , early graft angiography result : 1. low per patient angiographic bypass graft failure ( least one graft ) rate ( define â‰¥75 % diameter stenosis least one bypass graft ) ( primary efficacy endpoint ) 2. low per graft failure rate , per graft occlusion rate , per patient bypass graft occlusion rate ( least one bypass graft ) ( secondary endpoint ) 3. low incidence major adverse cardiac event ( death , nonfatal myocardial infarction , nonfatal stroke , coronary revascularization , composite death/myocardial infarction ) ( secondary endpoint ) Intravascular ultrasonography near-infrared spectroscopy also perform least one bypass graft baseline ( early graft angiography group ) 12-month angiographic follow-up evaluate structural bypass graft change occur coronary artery bypass graft surgery ( secondary endpoint ) .</brief_summary>
	<brief_title>Cardiac CAtheterization Bypass Graft Patency Rate Optimization : CABG-PRO Randomized-controlled Pilot Study</brief_title>
	<detailed_description />
	<criteria>1 . Age &gt; 18 year 2 . Willing able give inform consent . The patient must able comply study procedure followup . 3 . Undergoing clinicallyindicated coronary artery bypass graft surgery 1 . Positive pregnancy test breastfeed 2 . Coexisting condition limit life expectancy le 12 month could affect patient 's compliance protocol 3 . Serum creatinine &gt; 2.5 mg/dL acute renal failure 4 . Severe peripheral arterial disease limit vascular access</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>coronary artery bypass graft surgery</keyword>
	<keyword>bypass graft</keyword>
	<keyword>angiography</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>coronary imaging</keyword>
	<keyword>coronary artery bypass graft surgery , bypass graft patency</keyword>
</DOC>